Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Jul;72(1):189–192. doi: 10.1038/bjc.1995.301

Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes.

Y Ikeda 1, M Mori 1, K Kajiyama 1, Y Haraguchi 1, O Sasaki 1, K Sugimachi 1
PMCID: PMC2034161  PMID: 7541237

Abstract

The immunohistochemical expression of tenascin was examined in the normal adult mucosa of the stomach, primary tumours and lymph node metastases of gastric cancer patients. In normal gastric tissue tenascin was expressed in the muscularis mucosae, muscularis propria and vessel walls, however it was not expressed in either the mucosal connective tissue or the stromal tissue in the submucosal layer. In gastric cancer, tenascin was expressed in 35 of 85 primary tumours, and in 8 of 25 metastases in lymph nodes. Tenascin was located in the fibrous stroma surrounding foci of cancer. The expression of tenascin in the primary tumour did not correlate with the depth of invasion, lymph node metastasis or prognosis. Tenascin appears during the process of either malignant transformation or tumour progression in gastric cancer, and the positive expression of tenascin may be useful as a stromal marker for the early detection of gastric cancer.

Full text

PDF
189

Images in this article

190Figure 1
on p.190

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aufderheide E., Chiquet-Ehrismann R., Ekblom P. Epithelial-mesenchymal interactions in the developing kidney lead to expression of tenascin in the mesenchyme. J Cell Biol. 1987 Jul;105(1):599–608. doi: 10.1083/jcb.105.1.599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aufderheide E., Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J Cell Biol. 1988 Dec;107(6 Pt 1):2341–2349. doi: 10.1083/jcb.107.6.2341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chiquet-Ehrismann R., Kalla P., Pearson C. A., Beck K., Chiquet M. Tenascin interferes with fibronectin action. Cell. 1988 May 6;53(3):383–390. doi: 10.1016/0092-8674(88)90158-4. [DOI] [PubMed] [Google Scholar]
  4. Chiquet-Ehrismann R., Mackie E. J., Pearson C. A., Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986 Oct 10;47(1):131–139. doi: 10.1016/0092-8674(86)90374-0. [DOI] [PubMed] [Google Scholar]
  5. Chiquet-Ehrismann R., Matsuoka Y., Hofer U., Spring J., Bernasconi C., Chiquet M. Tenascin variants: differential binding to fibronectin and distinct distribution in cell cultures and tissues. Cell Regul. 1991 Nov;2(11):927–938. doi: 10.1091/mbc.2.11.927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chiquet-Ehrismann R. What distinguishes tenascin from fibronectin? FASEB J. 1990 Jun;4(9):2598–2604. doi: 10.1096/fasebj.4.9.1693347. [DOI] [PubMed] [Google Scholar]
  7. Chiquet M., Fambrough D. M. Chick myotendinous antigen. I. A monoclonal antibody as a marker for tendon and muscle morphogenesis. J Cell Biol. 1984 Jun;98(6):1926–1936. doi: 10.1083/jcb.98.6.1926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Erickson H. P., Bourdon M. A. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989;5:71–92. doi: 10.1146/annurev.cb.05.110189.000443. [DOI] [PubMed] [Google Scholar]
  9. Howeedy A. A., Virtanen I., Laitinen L., Gould N. S., Koukoulis G. K., Gould V. E. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest. 1990 Dec;63(6):798–806. [PubMed] [Google Scholar]
  10. Jones F. S., Burgoon M. P., Hoffman S., Crossin K. L., Cunningham B. A., Edelman G. M. A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2186–2190. doi: 10.1073/pnas.85.7.2186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Mackie E. J., Chiquet-Ehrismann R., Pearson C. A., Inaguma Y., Taya K., Kawarada Y., Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4621–4625. doi: 10.1073/pnas.84.13.4621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  13. Nakamura K., Sugano H., Takagi K. Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gan. 1968 Jun;59(3):251–258. [PubMed] [Google Scholar]
  14. Natali P. G., Nicotra M. R., Bartolazzi A., Mottolese M., Coscia N., Bigotti A., Zardi L. Expression and production of tenascin in benign and malignant lesions of melanocyte lineage. Int J Cancer. 1990 Oct 15;46(4):586–590. doi: 10.1002/ijc.2910460406. [DOI] [PubMed] [Google Scholar]
  15. Natali P. G., Nicotra M. R., Bigotti A., Botti C., Castellani P., Risso A. M., Zardi L. Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues. Int J Cancer. 1991 Apr 1;47(6):811–816. doi: 10.1002/ijc.2910470603. [DOI] [PubMed] [Google Scholar]
  16. Oike Y., Hiraiwa H., Kawakatsu H., Nishikai M., Okinaka T., Suzuki T., Okada A., Yatani R., Sakakura T. Isolation and characterization of human fibroblast tenascin. An extracellular matrix glycoprotein of interest for developmental studies. Int J Dev Biol. 1990 Jun;34(2):309–317. [PubMed] [Google Scholar]
  17. Pearson C. A., Pearson D., Shibahara S., Hofsteenge J., Chiquet-Ehrismann R. Tenascin: cDNA cloning and induction by TGF-beta. EMBO J. 1988 Oct;7(10):2977–2982. doi: 10.1002/j.1460-2075.1988.tb03160.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Probstmeier R., Martini R., Schachner M. Expression of J1/tenascin in the crypt-villus unit of adult mouse small intestine: implications for its role in epithelial cell shedding. Development. 1990 Jun;109(2):313–321. doi: 10.1242/dev.109.2.313. [DOI] [PubMed] [Google Scholar]
  19. Riedl S. E., Faissner A., Schlag P., Von Herbay A., Koretz K., Möller P. Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology. 1992 Aug;103(2):400–406. doi: 10.1016/0016-5085(92)90827-l. [DOI] [PubMed] [Google Scholar]
  20. Sakai T., Kawakatsu H., Hirota N., Yokoyama T., Sakakura T., Saito M. Specific expression of tenascin in human colonic neoplasms. Br J Cancer. 1993 May;67(5):1058–1064. doi: 10.1038/bjc.1993.194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sakakura T., Ishihara A., Yatani R. Tenascin in mammary gland development: from embryogenesis to carcinogenesis. Cancer Treat Res. 1991;53:383–400. doi: 10.1007/978-1-4615-3940-7_18. [DOI] [PubMed] [Google Scholar]
  22. Shoji T., Kamiya T., Tsubura A., Hatano T., Sakakura T., Yamamoto M., Morii S. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas. Virchows Arch A Pathol Anat Histopathol. 1992;421(1):53–56. doi: 10.1007/BF01607139. [DOI] [PubMed] [Google Scholar]
  23. Soini Y., Kamel D., Apaja-Sarkkinen M., Virtanen I., Lehto V. P. Tenascin immunoreactivity in normal and pathological bone marrow. J Clin Pathol. 1993 Mar;46(3):218–221. doi: 10.1136/jcp.46.3.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Soini Y., Päkkö P., Nuorva K., Kamel D., Linnala A., Virtanen I., Lehto V. P. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol. 1993 Aug;100(2):145–150. doi: 10.1093/ajcp/100.2.145. [DOI] [PubMed] [Google Scholar]
  25. Sugano H., Nakamura K., Kato Y. Pathological studies of human gastric cancer. Acta Pathol Jpn. 1982;32 (Suppl 2):329–347. [PubMed] [Google Scholar]
  26. Vollmer G., Siegal G. P., Chiquet-Ehrismann R., Lightner V. A., Arnholdt H., Knuppen R. Tenascin expression in the human endometrium and in endometrial adenocarcinomas. Lab Invest. 1990 Jun;62(6):725–730. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES